Recent revelations from the National Institutes of Health (NIH) have illuminated troubling issues regarding research integrity in neuroscience, particularly concerning Dr. Eliezer Masliah, a prominent figure formerly leading the neuroscience division at the National Institute on Aging (NIA). On Thursday, the NIH made public its findings that Masliah engaged in research misconduct, namely the manipulation
Health
Hemophilia B, a genetic disorder characterized by insufficient clotting factor IX, has long required chronic management through regular intravenous infusions. However, the landscape of treatment is changing with recent advancements in gene therapy. The pivotal BENEGENE-2 trial explored the efficacy of fidanacogene elaparvovec (also known as Beqvez), a promising genetic intervention that allows many patients
The expansion of Medicaid has been a pivotal point in the discussion around health care accessibility and equity in the United States. Initiatives to increase health insurance coverage for low-income populations are essential when considering the relationship between insurance status and health outcomes. Recent analyses stemming from the Oregon Health Insurance Experiment provide a crucial
In the wake of a catastrophic incident that has left Lebanon reeling, the emotional toll of war is vividly depicted through the lens of one dedicated ophthalmologist, Elias Jaradeh. As hospitals battle an influx of patients suffering from particularly horrific eye injuries—resulting from a cascade of detonations attributed to walkie-talkies and pagers—the crisis has drawn
Retail pharmacy, often characterized by bustling counters and quick transactions, hides a significant challenge beneath its surface: the physical and psychological toll it takes on its workers. As I reflect on my tenure in this field, especially during my internship in 2016, I am reminded of the long hours and grueling conditions that many pharmacy
Multiple sclerosis (MS) is a complex neurological condition that predominantly affects young adults, with varying degrees of severity and course among individuals. Recent research has illuminated a concerning trend in the treatment of relapsing forms of MS: women, who account for a significant proportion of MS patients, are less likely than men to receive appropriate
The Federal Trade Commission (FTC) has initiated a lawsuit against three major pharmacy benefit managers (PBMs)—Caremark, Express Scripts, and OptumRx—accusing them of employing anti-competitive practices that have significantly increased insulin prices for individuals living with diabetes. PBMs, which are responsible for administering prescription drug benefits for health insurers and large employers, control a substantial share
In the intricate realm of American healthcare, political influence, personal anecdotes, and scientific advancements weave a complex tapestry that defines public health outcomes. As we approach the upcoming elections, the role of political figures, such as Robert F. Kennedy Jr., raises significant questions about the future direction of health policymaking in the United States. The
In recent months, a plethora of health studies and findings have drawn significant attention on various fronts, from the benefits of coffee consumption to the repercussions of specific health policies. This article aims to synthesize and analyze these significant developments, emphasizing their implications and our evolving understanding of health and wellness. A comprehensive analysis from
The recent approval of ribociclib (Kisqali) by the U.S. Food and Drug Administration (FDA) marks a significant milestone in the management of early high-risk breast cancer. Previously indicated for metastatic breast cancer, ribociclib is now authorized for use as an adjuvant therapy in patients presenting with hormone receptor-positive and HER2-negative tumors, specifically those classified as